ArticleCancers2022

Preclinical Efficacy and Toxicology Evaluation of RAC1 Inhibitor 1A-116 in Human Glioblastoma Models.

Georgina A Cardama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.